肾动脉狭窄

Parikh SA, Shishehbor MH, Gray BH, et al. SCAI expert consensus statement for renal artery stenting appropriate use. Catheter Cardiovasc Interv. 2014;84:1163-1171.

• 全文
• 摘要

Slovut DP, Olin JW. Fibromuscular dysplasia. N Engl J Med. 2004;350:1862-1871.

• 摘要

Tendera M, Aboyans V, Bartelink ML, et al; European Stroke Organisation Authors/Task Force Members. ESC guidelines on the diagnosis and treatment of peripheral artery diseases. Eur Heart J. 2011;32:2851-2906.

• 全文
• 摘要

Balk E, Raman G, Chung M, et al. Comparative effectiveness of management strategies for renal artery stenosis: 2007 update. Executive summary. Rockville, MD: Agency for Healthcare Research and Quality; 2007.

• 全文

Balk E, Raman G, Chung M, et al. Effectiveness of management strategies for renal artery stenosis: a systematic review. Ann Intern Med. 2006;145:901-912.

• 全文
• 摘要

Pierdomenico SD, Pierdomenico AM, Cuccurullo C, et al. Cardiac events in hypertensive patients with renal artery stenosis treated with renal angioplasty or drug therapy: meta-analysis of randomized trials. Am J Hypertens. 2012;25:1209-1214.

• 摘要

1.  Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med. 2001;344:431-442.

• 摘要

2.  Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic). Circulation. 2006;113:e463-e654.

• 全文
• 摘要

3.  Haller C, Keim M. Current issues in the diagnosis and management of patients with renal artery stenosis: a cardiologic perspective. Prog Cardiovasc Dis. 2003;46:271-286.

• 摘要

4.  Chonchol M, Linas S. Diagnosis and management of ischemic nephropathy. Clin J Am Soc Nephrol. 2006;1:172-181.

• 全文
• 摘要

5.  White CJ, Jaff MR, Haskal ZJ, et al. Indications for renal arteriography at the time of coronary arteriography. Circulation. 2006;114:1892-1895.

• 全文
• 摘要

6.  Parikh SA, Shishehbor MH, Gray BH, et al. SCAI expert consensus statement for renal artery stenting appropriate use. Catheter Cardiovasc Interv. 2014;84:1163-1171.

• 全文
• 摘要

7.  Kaplan NM. Renovascular hypertension. In: Kaplan NM, ed. Clinical hypertension. 8th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2002:381-403.

8.  Garovic VD, Textor SC. Renovascular hypertension and ischemic nephropathy. Circulation. 2005;112:1362-1374.

• 全文
• 摘要

9.  Hansen KJ, Edwards MS, Craven TE, et al. Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg. 2002;36:443-451.

• 摘要

10.  Fatica RA, Port FK, Young EW. Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States. Am J Kidney Dis. 2001;37:1184-1190.

• 摘要

11.  Slovut DP, Olin JW. Fibromuscular dysplasia. N Engl J Med. 2004;350:1862-1871.

• 摘要

12.  Eisenhauer AC, White CJ. Endovascular treatment of noncoronary obstructive vascular disease. In: Libby P, Bonow RO, Mann DL, et al., eds. Braunwald's heart disease. 8th ed. Philadelphia, PA: Elsevier Saunders; 2008:1532-1535.

13.  Mwipatayi BP, Beningfield SJ, White LE, et al. A review of the current treatment of renal artery stenosis. Eur J Vasc Endovasc Surg. 2005;29:479-488.

• 摘要

14.  Anderson JL, Halperin JL, Albert NM, et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127:1425-1443.

• 全文
• 摘要

15.  Tendera M, Aboyans V, Bartelink ML, et al; European Stroke Organisation Authors/Task Force Members. ESC guidelines on the diagnosis and treatment of peripheral artery diseases. Eur Heart J. 2011;32:2851-2906.

• 全文
• 摘要

16.  Davenport A, Anker SD, Mebazaa A, et al.; Acute Dialysis Quality Initiative (ADQI) Consensus Group. ADQI 7: the clinical management of the Cardio-Renal syndromes: work group statements from the 7th ADQI consensus conference. Nephrol Dial Transplant. 2010;25:2077-2089.

• 全文
• 摘要

17.  Zucchelli PC. Hypertension and atherosclerotic renal artery stenosis: diagnostic approach. J Am Soc Nephrol. 2002;13(suppl 3):S184-S186.

• 全文
• 摘要

18.  Gerhard-Herman M, Gardin JM, Jaff M, et al. Guidelines for noninvasive vascular laboratory testing: a report from the American Society of Echocardiography and the Society for Vascular Medicine and Biology. Vasc Med. 2006;11:183-200.

• 全文
• 摘要

19.  Olbricht CJ, Paul K, Prokop M, et al. Minimally invasive diagnosis of renal artery stenosis by spiral computed tomography angiography. Kidney Int. 1995;48:1332-1337.

• 摘要

20.  Radermacher J. Resistive index: an ideal test for renovascular disease or ischemic nephropathy? Nat Clin Pract Nephrol. 2006;2:232-233.

• 摘要

21.  Mangiacapra F, Trana C, Sarno G, et al. Translesional pressure gradients to predict blood pressure response after renal artery stenting in patients with renovascular hypertension. Circ Cardiovasc Interv. 2010;3:537-542.

• 全文
• 摘要

22.  Leesar MA, Varma J, Shapira A, et al. Prediction of hypertension improvement after stenting of renal artery stenosis: comparative accuracy of translesional pressure gradients, intravascular ultrasound, and angiography. J Am Coll Cardiol. 2009;53:2363-2371.

• 全文
• 摘要

23.  De Bruyne B, Manoharan G, Pijls NH, et al. Assessment of renal artery stenosis severity by pressure gradient measurements. J Am Coll Cardiol. 2006;48:1851-1855.

• 全文
• 摘要

24.  UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.

• 摘要

25.  Gerstein HC, Miller ME, Byington RP, et al; Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545-2559.

• 全文
• 摘要

26.  Patel A, MacMahon S, Chalmers J, et al; The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560-2572.

• 全文
• 摘要

27.  Miyamori I, Yasuhara S, Takeda Y, et al. Effects of converting enzyme inhibition on split renal function in renovascular hypertension. Hypertension. 1986;8:415-421.

• 摘要

28.  Reams GP, Singh A, Logan KW, et al. Total and split renal function in patients with renovascular hypertension: effects of angiotensin-converting enzyme inhibition. J Clin Hypertens. 1987;3:153-163.

• 摘要

29.  Plouin PF, Chatellier G, Darné B, et al; Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Hypertension. 1998;31:823-829.

• 全文
• 摘要

30.  Van Jaarsveld BC, Krijnen P, Pieterman H, et al; Dutch Renal Artery Stenosis Intervention Cooperative Study Group. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. N Engl J Med. 2000;342:1007-1014.

• 全文
• 摘要

31.  Webster J, Marshall F, Abdalla M, et al. Randomised comparison of percutaneous angioplasty vs. continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. J Hum Hypertens. 1998;12:329-335.

• 摘要

32.  Krijnen P, van Jaarsveld BC, Deinum J, et al. Which patients with hypertension and atherosclerotic renal artery stenosis benefit from immediate intervention? J Hum Hypertens. 2004;18:91-96.

• 摘要

33.  Cooper CJ, Murphy TP, Cutlip DE, et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med. 2014;370:13-22.

• 摘要

34.  Cheung CM, Patel A, Shaheen N, et al. The effects of statins on the progression of atherosclerotic renovascular disease. Nephron Clin Pract. 2007;107:c35-c42.

• 摘要

35.  Hanzel G, Balon H, Wong O, et al. Prospective evaluation of aggressive medical therapy for atherosclerotic renal artery stenosis, with renal artery stenting reserved for previously injured heart, brain, or kidney. Am J Cardiol. 2005;96:1322-1327.

• 摘要

36.  Uder M, Humke U. Endovascular therapy of renal artery stenosis: where do we stand today? Cardiovasc Intervent Radiol. 2005;28:139-147.

• 摘要

37.  Balk E, Raman G, Chung M, et al. Comparative effectiveness of management strategies for renal artery stenosis: 2007 update. Executive summary. Rockville, MD: Agency for Healthcare Research and Quality; 2007.

• 全文

38.  Balk E, Raman G, Chung M, et al. Effectiveness of management strategies for renal artery stenosis: a systematic review. Ann Intern Med. 2006;145:901-912.

• 全文
• 摘要

39.  Pierdomenico SD, Pierdomenico AM, Cuccurullo C, et al. Cardiac events in hypertensive patients with renal artery stenosis treated with renal angioplasty or drug therapy: meta-analysis of randomized trials. Am J Hypertens. 2012;25:1209-1214.

• 摘要

40.  Schreiber MJ, Pohl MA, Novick AC. The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am. 1984;11:383-392.

• 摘要

41.  Harding MB, Smith LR, Himmelstein SI, et al. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol. 1992;2:1608-1616.

• 摘要

42.  Franklin SS, Smith RD. Comparison of effects of enalapril plus hydrochlorothiazide versus standard triple therapy on renal function in renovascular hypertension. Am J Med. 1985;79:14-23.

• 摘要

43.  Tillman DM, Malatino LS, Cumming AM, et al. Enalapril in hypertension with renal artery stenosis: long-term follow-up and effects on renal function. J Hypertens Suppl. 1984;2:S93-S100.

• 摘要

44.  Alonso A, Lau J, Jaber BL, et al. Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials. Am J Kidney Dis. 2004;43:1-9.

• 摘要

45.  Pannu N, Wiebe N, Tonelli M, et al. Prophylaxis strategies for contrast-induced nephropathy. JAMA. 2006;295:2765-2779.

• 全文
• 摘要

46.  Pizzolo F, Mansueto G, Minniti S, et al. Renovascular disease: effect of ACE gene deletion polymorphism and endovascular revascularization. J Vasc Surg. 2004;39:140-147.

• 摘要

47.  Rocha-Singh K, Jaff MR, Rosenfield K. Evaluation of the safety and effectiveness of renal artery stenting after unsuccessful balloon angioplasty: the ASPIRE-2 study. J Am Coll Cardiol. 2005;46:776-783.

• 摘要

48.  White CJ, Ramee SR, Collins TJ, et al. Renal artery stent placement: utility in lesions difficult to treat with balloon angioplasty. J Am Coll Cardiol. 1997;30:1445-1450.

• 摘要

49.  Gill KS, Fowler RC. Atherosclerotic renal arterial stenosis: clinical outcomes of stent placement for hypertension and renal failure. Radiology. 2003;226:821-826.

• 摘要

50.  Dorros G, Jaff M, Mathiak L, et al. Multicenter Palmaz stent renal artery stenosis revascularization registry report: four-year followup of 1,058 successful patients. Catheter Cardiovasc Interv. 2002;55:182-188.

• 摘要

51.  van de Ven PJ, Kaatee R, Beutler JJ, et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet. 1999;353:282-286.

• 摘要

52.  Gonçalves JA, Amorim JE, Soares Neto MM, et al. Clinical efficacy of percutaneous renal revascularization with stent placement in atherosclerotic renovascular disease. Arq Bras Cardiol. 2007;88:85-90.

• 全文
• 摘要